ArticleFrontiers in immunology2026
Immunologically-based nutritional status assessment amongst preoperative colorectal cancer patients - does it link to TNM stage.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Disease-related malnutrition can develop in colorectal cancer (CRC) patients, negatively affecting postoperative clinical outcomes. Nutritional status should be assessed using standardised tools and laboratory parameters to identify malnourished patients and introduce personalised, targeted dietary interventions based on epigenetics, immunologically-related aspects, and gut microbiome. The primary aim of this study is to analyse the immunonutritional status of CRC patients in the preoperative period. The secondary aim is to assess the link between albumin-to-globulin ratio (AGR), prognostic nutritional index (PNI), and TNM staging. Patients and methods: This study initially included 21 patients with histopathological confirmation of CRC qualified for surgical resection of the tumour. Immunologically-related nutritional status parameters, i.e., AGR and PNI, were calculated for selected 12 patients. The optimal cut-off value of PNI was determined, allowing patients to be divided into two independent groups: PNI-low and PNI-high. The link between AGR, PNI, and TNM was analysed. Results: TNM classification of the 12 selected participants revealed that most participants classified as T3 (67%), lymph node metastasis was identified in 50% of patients, and there were no distant metastases. Among selected patients, the analysis of mean values of immunological laboratory tests showed that they were within the normal range, except for lymphocyte levels, which were reduced (22.03 ± 7.31%). The optimal cut-off value was set at 51.74 for PNI; thus, patients were accordingly divided into PNI-low and PNI-high groups (<51.74, 34% of cases; ≥51.74, 66%, respectively). PNI-low was initially associated with more advanced cases (based on T assessment) compared to PNI-high (100% versus 75%; respectively); however, it failed to reach statistical significance (p = 0.515; effect size 0.2889; CI 95%, CI = 0.0110-7.5681). Therefore, this finding should be interpreted with caution. Lymph node metastasis was found more often in the PNI-high group than in the PNI-low group. Conclusions: Overall concentrations of albumin and total protein were not decreased in CRC patients; however, these parameters allow calculation of AGR and PNI. The link between PNI-low and locally advanced cases of CRC based on T assessment can potentially exist; nevertheless, it should be confirmed with more clinical data. Lymph node metastasis was more often observed in the PNI-high group. This status is also related to higher levels of AGR. A PNI-low value is more related to local than distant pathological processes associated with CRC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.